פרופ' מירה ברק

Volovik, Y., Nimri-Ammouri, S., Adler, T., Barak, M. & Henig, C. (2023). Is this a true lambda free light chain?. Clinical Chemistry and Laboratory Medicine (CCLM), 61(2), e36-e37.

Bassal, R., Shohat, T., Levin, T., Pando, R., Shinar, E., Amichay, D., Barak, M., et al. (2022). The Concordance between Mumps and Rubella Sero-Positivity among the Israeli Population in 2015. Vaccines, 10(7), 996. MDPI AG. Retrieved from

Volovik, Yael & Nimri-Ammouri, Suheir & Rozenberg, Orit & Henig, Clara & Barak, Mira. (2021). Artefactual bands on urine protein immunofixation gels. Clinical Chemistry and Laboratory Medicine (CCLM). -1. .

Bassal, Ravit & Indenbaum, Victoria & Pando, Rakefet & Levin, Tal & Shinar, Eilat & Amichay, Doron & Barak, Mira & Ben-Dor, Anat & Bar Chaim, ADINA & Mendelson, Ella & Cohen, Dani & Shohat, Tamy. (2020). Seropositivity of measles antibodies in the Israeli population prior to the nationwide 2018 – 2019 outbreak. Human Vaccines and Immunotherapeutics. .

Peiffer KH, Kuhnhenn L, Stelzl E, Dietz J, Susser S, Tal AO, Finkelmeier F, Zuckerman E, Cornberg M, Barak M, Piazzolla V, Mangia A, Zeuzem S, Kessler HH, Vermehren J, Sarrazin C. Performance of Three Common Hepatitis C Virus (HCV) Genotyping Assays for Identification of HCV Genotype 2/1 Chimeras. J Clin Microbiol. 2019 Jun 25;57(7):e00060-19. PMID: 31043467; PMCID: PMC6595458.

Tadmor T, Braester A, Najib D, Aviv A, Herishanu Y, Yuklea M, Shvidel L, Rahimi-Levene N, Ruchlemer R, Arad A, Fogl C, Henig C, Barak M, Magal L, Polliack A, Townsend K; Israeli CLL study group. A new risk model to predict time to first treatment in chronic lymphocytic leukemia based on heavy chain immunoparesis and summated free light chain. Eur J Haematol. 2019 Oct;103(4):335-341. . Epub 2019 Jul 26. PMID: 31278876.

Bassal, Ravit & Shohat, Tamy & Kaufman, Zalman & Mannasse, Batya & Shinar, Eilat & Amichay, Doron & Barak, Mira & Ben-Dor, Anat & Bar Chaim, ADINA & Cohen, Dani & Mendelson, Ella & Lustig, Yaniv. (2017). The seroprevalence of West Nile Virus in Israel: A nationwide cross sectional study. .

Susser S, Dietz J, Schlevogt B, Zuckerman E, Barak M, Piazzolla V, Howe A, Hinrichsen H, Passmann S, Daniel R, Cornberg M, Mangia A, Zeuzem S, Sarrazin C. Origin, prevalence and response to therapy of hepatitis C virus genotype 2k/1b chimeras. J Hepatol. 2017 Oct;67(4):680-686.